secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2025-05-16T23:59:59+00:00
Accession:  0001079973-25-000886
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q1 revenue up 6% to $2.28M, net loss $(293k) from $(284k) YoY
---------------------------------------------------------------------

- Q1 net revenue $2.277M (+6% YoY); net loss $(293k) or $(0.11) per diluted share.
- Gross margin improved to 39.9% from 38.8%; R&D spending >20% of revenue for SpinDx development.
- SpinDx beta testing with Anschutz Medical Center imminent; commercial launch targeted for 2026.
- Applied for OTCID listing on OTC Markets, effective July 1, 2025, replacing OTC Pink.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997325000886/0001079973-25-000886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997325000886/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-25-000886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer